765 related articles for article (PubMed ID: 18990014)
21. Uterine sarcomas: the Curie Institut experience. Prognosis factors and adjuvant treatments.
Chauveinc L; Deniaud E; Plancher C; Sastre X; Amsani F; de la Rochefordiere A; Rozemberg H; Clough KB
Gynecol Oncol; 1999 Feb; 72(2):232-7. PubMed ID: 10021306
[TBL] [Abstract][Full Text] [Related]
22. Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patients.
Bodner K; Bodner-Adler B; Obermair A; Windbichler G; Petru E; Mayerhofer S; Czerwenka K; Leodolter S; Kainz C; Mayerhofer K
Gynecol Oncol; 2001 May; 81(2):160-5. PubMed ID: 11330943
[TBL] [Abstract][Full Text] [Related]
23. The Impact of Adjuvant Therapy on Survival and Recurrence Patterns in Women With Early-Stage Uterine Carcinosarcoma: A Multi-institutional Study.
Guttmann DM; Li H; Sevak P; Grover S; Jacobson G; Feldman A; Rubin S; Chu C; Bhatia S; Elshaikh MA; Lin LL
Int J Gynecol Cancer; 2016 Jan; 26(1):141-8. PubMed ID: 26509850
[TBL] [Abstract][Full Text] [Related]
24. Clinical outcome of patients with uterine sarcomas.
Sharma DN; Rath GK; Kumar S; Kumar L; Bhatla N; Gandhi AK; Hariprasad R
J Cancer Res Ther; 2011; 7(3):270-4. PubMed ID: 22044806
[TBL] [Abstract][Full Text] [Related]
25. [A clinical analysis of 153 uterine sarcomas].
Bai P; Sun J; Chao H
Zhonghua Fu Chan Ke Za Zhi; 1997 Mar; 32(3):163-7. PubMed ID: 9596892
[TBL] [Abstract][Full Text] [Related]
26. The retrospective analysis of patients with uterine sarcomas: A single-center experience.
Terek MC; Akman L; Hursitoglu BS; Sanli UA; Ozsaran Z; Tekindal MA; Dikmen Y; Zekioglu O; Ozsaran AA
J Cancer Res Ther; 2016; 12(1):309-13. PubMed ID: 27072256
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of treatment results and prognostic factors of uterine sarcoma: A single-center experience.
Momtahan M; Emami F; Sari Aslani F; Akbarzadeh-Jahromi M
J Chin Med Assoc; 2020 Jan; 83(1):84-88. PubMed ID: 31517774
[TBL] [Abstract][Full Text] [Related]
28. Extraskeletal Myxoid Chondrosarcomas: Combined Modality Therapy With Both Radiation and Surgery Improves Local Control.
Bishop AJ; Bird JE; Conley AP; Roland CL; Moon BS; Satcher RL; Livingston JA; Patel S; Wang WL; Lazar AJ; Lewis VO; Lin PP; Guadagnolo BA
Am J Clin Oncol; 2019 Oct; 42(10):744-748. PubMed ID: 31436747
[TBL] [Abstract][Full Text] [Related]
29. Localized high grade endometrial stromal sarcoma and localized undifferentiated uterine sarcoma: a retrospective series of the French Sarcoma Group.
Meurer M; Floquet A; Ray-Coquard I; Bertucci F; Auriche M; Cordoba A; Piperno-Neumann S; Salas S; Delannes M; Chevalier T; Italiano A; Blay JY; Mancini J; Pautier P; Duffaud F
Int J Gynecol Cancer; 2019 May; 29(4):691-698. PubMed ID: 30772825
[TBL] [Abstract][Full Text] [Related]
30. On the apparent failure of adjuvant pelvic radiotherapy to improve survival for women with uterine sarcomas confined to the uterus.
Dusenbery KE; Potish RA; Argenta PA; Judson PL
Am J Clin Oncol; 2005 Jun; 28(3):295-300. PubMed ID: 15923804
[TBL] [Abstract][Full Text] [Related]
31. Uterine sarcoma. Clinico-pathological characteristics and outcome.
Sait HK; Anfinan NM; El Sayed ME; Alkhayyat SS; Ghanem AT; Abayazid RM; Sait KH
Saudi Med J; 2014 Oct; 35(10):1215-22. PubMed ID: 25316466
[TBL] [Abstract][Full Text] [Related]
32. [Clinical review of 97 patients with endometrial stromal sarcoma].
Li N; Wu LY; Zhang HT; An JS; Li XG; Ma SK
Zhonghua Fu Chan Ke Za Zhi; 2008 Feb; 43(2):115-9. PubMed ID: 18683750
[TBL] [Abstract][Full Text] [Related]
33. Ovarian preservation in stage I low-grade endometrial stromal sarcomas.
Li AJ; Giuntoli RL; Drake R; Byun SY; Rojas F; Barbuto D; Klipfel N; Edmonds P; Miller DS; Karlan BY
Obstet Gynecol; 2005 Dec; 106(6):1304-8. PubMed ID: 16319256
[TBL] [Abstract][Full Text] [Related]
34. Low grade endometrial stromal sarcoma of uterine: review of 17 cases.
Behtash N; Akhavan S; Gilani MM; Mousavi A; Ghaemmaghami F; Mazhari MM
Acta Med Iran; 2011; 49(9):619-24. PubMed ID: 22052146
[TBL] [Abstract][Full Text] [Related]
35. Uterine sarcoma: twenty-seven years of experience.
Livi L; Paiar F; Shah N; Blake P; Villanucci A; Amunni G; Barca R; Judson I; Lodge N; Meldolesi E; Simontacchi G; Piperno G; Galardi A; Scoccianti S; Biti GP; Harmer C
Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1366-73. PubMed ID: 14630275
[TBL] [Abstract][Full Text] [Related]
36. [Sarcoma of the endometrium. Epidemiology and prognostic factors. Apropos of a study of 22 cases].
Calais G; Frinot-Rousseau S; Body G; Fetissoff F; Le Floch O; Lansac J
J Gynecol Obstet Biol Reprod (Paris); 1989; 18(7):885-9. PubMed ID: 2614028
[TBL] [Abstract][Full Text] [Related]
37. Prognostic factors and outcome in women with uterine sarcoma.
Denschlag D; Masoud I; Stanimir G; Gilbert L
Eur J Surg Oncol; 2007 Feb; 33(1):91-5. PubMed ID: 17174517
[TBL] [Abstract][Full Text] [Related]
38. Impact of adjuvant treatment modalities on the management of patients with stages I-II endometrial stromal sarcoma.
Malouf GG; Duclos J; Rey A; Duvillard P; Lazar V; Haie-Meder C; Balleyguier C; Morice P; Lhommé C; Pautier P
Ann Oncol; 2010 Oct; 21(10):2102-2106. PubMed ID: 20305035
[TBL] [Abstract][Full Text] [Related]
39. Patterns of failure and prognostic factor analyses in locally advanced cervical cancer patients staged by magnetic resonance imaging and treated with curative intent.
Narayan K; Fisher RJ; Bernshaw D
Int J Gynecol Cancer; 2008; 18(3):525-33. PubMed ID: 18476950
[TBL] [Abstract][Full Text] [Related]
40. A multivariate analysis of clinicopathologic factors for predicting outcome in uterine sarcomas.
Wolfson AH; Wolfson DJ; Sittler SY; Breton L; Markoe AM; Schwade JG; Houdek PV; Averette HE; Sevin BU; Penalver M
Gynecol Oncol; 1994 Jan; 52(1):56-62. PubMed ID: 8307502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
